HE homepage

AI cardiology heart artificial intelligence deep learning

According to Nanox.AI, previously known as Zebra Medical Vision, the updated software helps "bridge the divide between radiology and cardiology."

pharmaceutical drug approval process

An exclusivity agreement is stopping Liquidia Corporation from gaining full FDA approval of its new inhalation powder for pulmonary arterial hypertension. The company said it is disappointed with the agency's decision and plans to "take quick action."

V-Wave has gained considerable attention or its Ventura Interatrial Shunt System, a small implantable device designed to reduce pressure on the left atrium and the lungs in patients with heart failure with reduced ejection fraction (HFrEF). The Ventura device includes a nitinol hourglass-shaped frame that anchors to the patient’s fossa ovalis in a way that prevents migration or embolization. It is implanted via an interventional procedure with fluoroscopy and echocardiography guidance.

V-Wave has gained considerable attention for its Ventura Interatrial Shunt System, a small implantable device designed to reduce pressure on the left atrium and lungs of HFrEF patients.

ai in healthcare artificial intelligence digital transformation

When a hacker breaches a business, the usual break-and-entry point is a hole opened by a phishing scam. 

artificial intelligence healthcare future

Smart machines have watched over the little bundle of joy practically since conception—and will be an omnipresent part of his or her life for decades to come. What can we tell this individual their life will be like?

money cybersecurity ransomware health IT data breach hacker

The Michigan-based health system is not sure what data may have been taken during the breach. An investigation is ongoing.

Around the web

The approval, made as part of a special FDA pilot program, took just 50 days.